Sangamo Therapeutics Inc (SGMO) — Cash Flow Reinvestment Rate
Sangamo Therapeutics Inc (SGMO) has a Cash Flow Reinvestment Rate of 0.03x as of September 2024, reinvesting $348.00K (capex $115.00K plus investments $233.00K) from operating cash flow of $11.76 Million. Check SGMO cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sangamo Therapeutics Inc Cash Flow Reinvestment Rate (2017–2020)
Historical reinvestment intensity for Sangamo Therapeutics Inc across 3 annual periods. Explore Sangamo Therapeutics Inc (SGMO) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Sangamo Therapeutics Inc (2017–2020)
Year-by-year capital reinvestment analysis for Sangamo Therapeutics Inc. For live market cap and broader valuation context, see how much is Sangamo Therapeutics Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 1.59x | $270.92 Million | $169.88 Million | $14.71 Million | ▼ -42.2% |
| 2018 | 2.76x | $102.46 Million | $37.15 Million | $43.06 Million | ▼ -60.2% |
| 2017 | 6.92x | $77.40 Million | $11.18 Million | $3.75 Million | — |